Tarsus Pharmaceuticals, Inc. · 5 hours ago
Intern, Pharmaceutical Development
Irvine, California, United States
Internship
Hybrid
Intern
$45/hr - $45/hrTarsus Pharmaceuticals is seeking a Pharmaceutical Development Intern to support the design, execution, and evaluation of studies that advance their pharmaceutical formulations. The role involves performing laboratory-based development activities, analyzing data, and communicating findings to project teams.
BiopharmaBiotechnologyLife Science
Responsibilities
Assist in planning, conducting, and troubleshooting formulation activities for new drug products intended for pre-clinical evaluation, with an emphasis on liquid and topical dosage forms
Review internal and external technical documents and contribute to authoring technical memos and reports
Maintain accurate and compliant documentation, including laboratory notebooks, following proper data integrity and documentation practices
Review laboratory records and handle data with the highest standards of integrity and ethics
Collaborate cross-functionally to support ongoing development programs
Perform other duties as assigned
Qualification
Required
PharmD or graduate student majoring in Pharmacology, Pharmaceutical Sciences, Chemistry, or a related field
Ability to follow safety requirements and adhere to company policies
Strong written, verbal, interpersonal, and presentation skills
Demonstrated ability to collaborate effectively, meet timelines, and support program goals
A critical thinker with strong organizational skills and the ability to work independently on assigned projects
Preferred
Prior project experience in drug development, formulation, or drug-delivery systems is a plus
Experience with liquid or gel formulations; familiarity with analytical techniques (e.g., UV, HPLC); and hands-on formulation development experience
Benefits
Snacks and drinks
Occasional catered meals
Lunch and learns
Development opportunities
Offsite volunteering
Company-wide social events
Company
Tarsus Pharmaceuticals, Inc.
Tarsus (NASDAQ:TARS) is a biopharmaceutical company that applies proven science and new technology to revolutionize treatment for patients, starting with eye care.
Founded in 2017
201-500 employees
Funding
Current Stage
Public CompanyTotal Funding
$710.6MKey Investors
Pharmakon AdvisorsVivo Capital
2025-03-12Post Ipo Equity· $125M
2024-04-19Post Ipo Debt· $75M
2024-02-29Post Ipo Equity· $100M
Leadership Team
Jeffrey Farrow
Chief Financial Officer and Chief Strategy Officer
Bobak Azamian
Chairman
Recent News
Tarsus Pharmaceuticals, Inc
2025-11-06
Tarsus Pharmaceuticals, Inc
2025-11-05
2025-11-05
Company data provided by crunchbase